While some gynaecological cancers, such as cervical cancer, are more widely discussed, vulval cancer – which the HPV vaccine also helps protect against – is mentioned far less frequently.

A patient turned advocate underscores the importance of education, especially for those facing a rare cancer. Stacey Hudson Padova had never heard of vulvar cancer until she received a diagnosis in ...

FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer—A Multicenter Prospective Study Reports of MMS for early vulvar SCC are limited, but cases of successful ...

A retrospective study reports that the incidence of vulval SCC has remained stable over the past decade, but the diagnosis is delayed due to poor awareness and clinical presentation challenges.

Treatment of vulvar carcinoma (VC) is challenging. The objectives of this review were to describe for clinicians the epidemiologic and clinical aspects of VC, the standard of care in terms of primary ...

Sentinel lymph node dissection in women with vulvar malignancies allowed gynecologic oncology surgeons to identify and remove just the sentinel nodes and follow the patients for complications and ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the ...

Vulvar squamous cell carcinoma (VSCC), a rare gynecologic malignancy, has been rising in incidence. Molecular classification on the basis of human papilloma virus (HPV) and tumor protein 53 (p53) ...

Sentinel Node Biopsy Safe for Vulvar Squamous Cell Cancer For women with squamous cell carcinoma (SCC) of the vulva, sentinel lymph node (SLN) biopsy may be safely used in place of inguinal femoral ...

Treatment changes for the rare illness include less invasive surgery. A RECENT GUIDELINE for the management of vulvar cancer, issued by the National Comprehensive Cancer Network (NCCN), outlines the ...

Nov. 5 -- WEDNESDAY, Nov. 4 (HealthDay News) -- A vaccine that targets human papillomavirus (HPV) is able to stop precancerous lesions in the vulva from progressing into full-blown malignancies, Dutch ...